1.0Pharmacology/pharmBetsy Clarke/pharm/author/bclarke/rich600338<blockquote class="wp-embedded-content" data-secret="nZKEtK50en"><a href="/pharm/directory/alisha-holtzhausen-hanks-phd/">Alisha Holtzhausen Hanks, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/pharm/directory/alisha-holtzhausen-hanks-phd/embed/#?secret=nZKEtK50en" width="600" height="338" title="“Alisha Holtzhausen Hanks, PhD” — Pharmacology" data-secret="nZKEtK50en" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /pharm/wp-content/uploads/sites/930/2023/05/AH-Headshot-2.jpg300300Research Interests Tumor immunology and immunotherapy Research Synopsis I am interested in the interplay between the immune system and tumor cells. Specifically, we are focusing on mechanisms governed by the TAM RTKs that suppress the immune response to tumors. Additionally, we are investigating how myeloid cells contribute to adaptive resistance to immunotherapy. Publications View complete … Read more